UBS Maintains Buy on American Healthcare REIT, Raises Price Target to $63

American Healthcare REIT, Inc.

American Healthcare REIT, Inc.

AHR

0.00

UBS analyst Michael Goldsmith maintains American Healthcare REIT (NYSE: AHR) with a Buy and raises the price target from $60 to $63.